The science on covid and Ivermectin has been settled for years, it works. Fortunately there is action by groups like the Indian Bar Association charging W.H.O. with mass murder. The actions will continue. There will be justice as the world wakes up.
Indian Bar Association sues WHO scientist over Ivermectin
"The Indian Bar Association (IBA) sued WHO Chief Scientist Dr. Soumya Swaminathan on May 25, accusing her in a 71-point brief of causing the deaths of Indian citizens by misleading them about Ivermectin.
Point 56 states, “That your misleading tweet on May 10, 2021, against the use of Ivermectin had the effect of the State of Tamil Nadu withdrawing Ivermectin from the protocol on May 11, 2021, just a day after the Tamil Nadu government had indicated the same for the treatment of COVID-19 patients.”
The Indian Bar Association has warned action under section 302 etc. of the Indian Penal Code against Dr. Soumya Swaminathan and others, for murder of each person dying due to obstruction in treatment of COVID-19 patient effectively by Ivermectin. Punishment under section 302 of the Indian Penal Code is death penalty or life imprisonment."
Ivermectin for COVID-19: real-time meta analysis of 99 studies (ivmmeta) (c19ivm.org)
- “Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients”

Conclusion: “According to the findings obtained, ivermectin can provide an increase in clinical recovery, improvement in prognostic laboratory parameters and a decrease in mortality rates even when used in patients with severe COVID-19. Consequently, ivermectin should be considered as an alternative drug that can be used in the treatment of COVID-19 disease or as an additional option to existing protocols.”
2.
“The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial”

Conclusion: “The positive signal found in this pilot warrants the conduction of larger trials using ivermectin for the early treatment of COVID-19.Such trials should include patients with risk factors for severe diseaseas well as patients with pneumonia. The potential for a mechanism of action different to direct antiviral effect also opens the door for preexposure prophylaxis in high-risk groups.”
3.
“Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID 19”

Conclusion: “we consider IDEA protocol to be a scientifically based, low-cost treatment and sustainable healthcare strategy with a favorable benefit-risk ratio, based on the results reported in this article: reduction in overall mortality to one fourth, reduction in mortality of hospitalized patients to one eighth and no progression of mild cases to moderate or severe cases.”
4.
“Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomized Clinical Trial”
Conclusion: “Ivermectin is suggested to be a promising effective chemoprophylactic drug against COVID-19. Ivermectin is inexpensive, available and quite safe drug. As this is the first report regarding use of ivermectin in COVID-19 prophylaxis, it is very appropriate to promptly and rigorously study this drug further.”
5.
“Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial)”
Conclusion: “The mean time to stay in the hospital was significantly lower in IVM group compared with the controls…Add-on use of IVM to HCQ and AZT had better effectiveness, shorter hospital stay, and relatively safe compared with controls. however, a larger prospective study with longer follow up may be needed to validate these results.”
6.
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
“Close to 70 clinical trials are currently in progress worldwide for SARS-CoV-2. Although few of these studies have been completed, the results that are available, as well as those from observational/retrospective studies, indicate clinical benefit.”